The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 9% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4. It reported earnings in this window, a natural checkpoint for the thesis.
3D Systems Corp
DDD · the NYSE · USD · Market cap $505M · 1,418 employees
3D Systems Corporation provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania.
PASS · Titan Ethical · score 70.0Price as of 3 Nov 2026Daily close, not a live quote
Screened 2026-11-03 · the tape above runs as of 04:06 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price2.73 USD at the 3 Nov 2026 close
- Fair valueUnder review: our model's value is 2.01x the price, above our 2.00x limit.
- Our regime readMarkdown, as of 3 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.25)
- Last reviewed3 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-03).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.25, read 2026-11-03
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
3D Systems Corp holds its Markdown at $2.73. The statistical read favours the sellers, held for 42 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 42 days |
| Price at the screen | $2.73 |
| Valuation | N/A trailing · -24.32 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 2.78 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 30.37% | Below 33% | Interest-bearing debt is just 30.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 34.39% | Below 49% | Money owed to the company is 34.4% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.02% | Below 5% | Only 1.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
3D Systems clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 30%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when DDD's ethical verdict changes
Today DDD passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 2.01x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets. The average target sits +101% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | -24.3x |
| EPS, trailing | -0.41 |
| EPS, forward | -0.13 |
| Revenue growth | -0.3%revenue is shrinking |
| Profit margin | -14.2%currently unprofitable |
| Return on equity | -21.3%not currently earning a positive return on equity |
| FCF yield | -2.35% |
| Debt to equity | 0.56moderate, manageable leverage |
| Current ratio | 3.40comfortably covers its short-term bills |
| Beta | 2.78much more volatile than the market |
| Short interest, float | 0.27% |
| 52-week range | 1.70 - 4.12 |
| Moat | NONE |
| Market cap | $505M |
| Employees | 1,418 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDDD trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 9% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 9% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 9% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 9% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 9% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 9% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 0% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (2 analysts) rates it none, with a mean price target of $4.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3D Systems Donates NextDent 300 3D Printer to Remote Area Medical to Expand Access to Free Denture Care in the U.S. Yahoo Finance · 5d ago
- Precision Resource Breaks Ground on Two New Production Additive Manufacturing Facilities and Expands Value-Added Services in Partnership with 3D Systems Yahoo Finance · 6d ago
- 3D Systems Announces Date of Third Quarter 2026 Financial Results Yahoo Finance · 8d ago
- CORRECTION - 3D Systems Opens New Industrial Technology Center to Expand America's Advanced Manufacturing Capacity Yahoo Finance · 12d ago
- 3D Systems Opens New Industrial Technology Center to Expand America's Advanced Manufacturing Capacity Yahoo Finance · 13d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $2.51 | +17.3% | · | $1,173 | +17.3% |
| 2 months | $1.92 | +53.4% | · | $1,534 | +53.4% |
| 3 months | $2.39 | +23.2% | · | $1,232 | +23.2% |
| 6 months | $1.97 | +49.5% | · | $1,495 | +49.5% |
| 1 year | $1.84 | +60.1% | · | $1,601 | +60.1% |
| 2 years | $4.01 | -26.6% | · | $734 | -26.6% |
| 3 years | $9.78 | -69.9% | · | $301 | -69.9% |
| 5 years | $29.83 | -90.1% | · | $99 | -90.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DDD does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.